In the late 1980s, scientists discovered for the first time autoantibodies that are associated with neurological diseases, first and foremost anti-Hu, anti-Ri and anti-Yo. Since then, test systems for these antibodies have become established in diagnostics and have enabled many life-saving medical findings.
Neuroimmunology has now advanced further: 52 different neural autoantibodies have found their way into diagnostics. Which these are, the diseases they are associated with and their diagnostic value is explained by Prof. Dr. med. Winfried Stöcker. In an interview with a colleague from the Polish subsidiary, the founder and CEO of EUROIMMUN AG not only provides an insight into the detection methods, but also talks about recent developments concerning biomarkers for neurodegenerative disorders, e.g. Alzheimer’s disease, Parkinson’s disease and multiple sclerosis.